AMBLor

Summary

AMBLor is a prognostic risk stratification test for identifying low-risk nonulcerated early-stage cutaneous melanoma.Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of AMBLor for the for identification of low-risk non-ulcerated early-stage cutaneous melanomas.
Based on the evidence identified, HTW’s Assessment Group concluded not to progress this topic to evidence appraisal.